At the news
? NEUTRALIMPACT 3/10 CLUSTER filed Mar 2, 2026 at 19:00 ET
Four C-suite executives at BioLife Solutions, including the CFO and Chief Quality and Operations Officer, sold shares in a coordinated open-market transaction on March 3, 2026, totaling $32,728 in value. The sales were small in absolute size and represent a negligible fraction of the company's $998M market cap. This appears to be routine portfolio management rather than a signal of material concern.
- Four C-suite executives sold shares on the same day (March 3, 2026) in open-market transactions.
- Total value of sales: $32,728 (aggregated across CFO, Chief Quality and Operations, Chief HR Officer, and Chief Marketing Officer).
- All transactions were coded as 'S' (open-market sale) at $20.74 per share.
- Total insider sales over the past 30 days amount to $33K, consistent with recent patterns.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access